Tip: follow the show's well-being in video

It shows the well-being, alternative medicine and spa that is right now and until February 8 in Paris Porte de Versailles.

On this occasion, it invites you to participate in a virtual exhibition on the forums.

For those who are lucky enough to visit the exhibition, the site also offers you the opportunity to meet with his coaches''stars'': Jean-Michel Cohen, Sybille Montignac, Jean-Michel Gurret Julie Impériali or Yves Rougier. Making appointments with upstream recommended Helene Neumager.

The program stand: meetings, games, coaching, elections and full of tricks and tips for better living. But also calculate your BMI, your IMG, your daily calorie expenditure, test your IQ and your ANC, discover the meaning of your name, or test your knowledge.

Aspirin has 110 years

The Romans used successfully willow bark (the base del'aspirine) to relieve the suffering of sick and wounded. In the first century AD the Roman physician advised Dioscuri compresses based herbal willow to cure gout and rhumatismes.Le physician of ancient Greece, Hippocrates also used willow bark to prepare recipes anesthetics and febrifuge.
In 1988 we launched this new market under the name aspirin.

In 1918 the deadliest pandemic in human history began in lemonade, she took between 20 and 50 million lives and aspirin is stopped.

It was the best recommendation and the product has been called "the medicine of the century" quickly became popular worldwide.

New opportunities: The interest of scholars of aspirin has been paid by the discovery of Professor in Pharmacology John Wein. In 1971 ila shown that aspirin has a direct influence on pain mediators, prostaglandins. Thus, if we take small doses of aspirin for a long time this will decrease the risk of thrombosis of coronary and cerebral arteries (that is to say, for the prevention of heart attack and stroke).

Through ongoing studies, the sphere of use of aspirin was much enlarged. It was established by example that aspirin increases the level of interferon and thus can help to fortify the refractory system.


"Recent studies conducted by American doctors have recommended this drug to cure certain forms of cancer. We study the effectiveness of this product in the fight complications of diabetes mellitus and senile dementia including Alzheimer's disease and l herpes. The experts also note that aspirin helps to cope with the height and relief of pressure, "announces the press release.

The siesta in the afternoon and diabetes?

The siesta in the afternoon increases the risk of diabetes mellitus type 2, announce the scholars of the University of Birmingham (Great Britain).

Having conducted a wide search of 16 thousand people involved, scientists have concluded: napping increases the risk of type 2 diabetes by 26%.

Scientists have two versions of the evolution of events: it may be that sleep during the afternoon shortens its duration during the night which is itself a risk factor for diabetes.

It is also possible that during recovery hormones that lower insulin levels, are activated. "Although sleep increases the risk of diabetes, poor heredity and obesity contribute much more," the scientists explain.


With this, we will continue looking for the negative effect of sleep in the afternoon with the exchange of sugar.

Survey of the Council of Europe on Conflict of Interest around influenza A and the business of untested vaccines

At the initiative of the Social Democrat Wolfgang German Wodarg also interviewed in the documentary "A virus that debate" (NDR for ARTE) we can see on this page, the Council of Europe launched a commission investigation of conflicts of interest between decision-making bodies and pharmaceutical companies producing vaccines. There could be an "urgent debate" during its Parliamentary Assembly in January. The companies are (finally!) Suspected of a huge disinformation that has a global business with vaccines uncertain.

Wolfgang Wodarg is himself a medical epidemiologist specializing in lung diseases and chairs the health committee in the Council of Europe. He does not mince words, and we would love to have such politicians in France, denouncing both the lack of transparency, lack of democratic control and multiple layers of conflicts of interest or corruption, between laboratories and national regulatory authorities and international.

Parliamentary inquiry into the links between experts, labs and policies in the management of influenza A H1N1? Support the initiative of Senator Autai

Relayed the past several initiatives of Senator Francis Autain, one of the very few French politicians to want to curb corruption Radicarl.net.jpgles excesses of the pharmaceutical industry and the vast network of conflicts of interest that maintained at the expense of the common good of citizens and our health.

We have, however, all elected to this, our men and women in politics: to represent the general interest and not kowtow to the financial strength and courtier of the pharmaceutical lobby group or some private interest whatsoever .
Yet it is clear that the abuses and excesses of the industry are legion, made possible by cronyism with policies that do nothing to fill the legislative vacuum and French law, and therefore to provide means of repression (and deterrence) in the area. Whatever the severity of the health scandal of cocooning, acts under the influence of such political, administrative officer, doctor or expert, you can not see any lawsuit brought by the French public powers. Neither them nor the pharmaceutical industry. And no opportunity for users and their associations have a defense and protection worthy of the name. On the contrary, the prosecution Silencing and other means of intimidation of citizens - to muzzle whistleblowers and any form of citizen expertise - flourish without anyone raises the question of the dangers of this phase any independent source and not interested.

No mechanism of participatory democracy does participation and effective citizen deliberation on political and health issues. No legislative does investigate and severely punish the excesses of industry. No safeguards exist, and there is no curb lobbying, conflicts of interest, revolving doors and other epiphenomena reflecting the same tendency to blithely trampling the interest in the name of profits and stock returns and any other the servants of industry, whether on the benches of political assemblies in health agencies, in medical offices or elsewhere.

It reiterates that Francis Autain merit him the confidence of users. It deserves the widest possible support for his work in public health. Work to which we all can and must participate in their own way, to finally start to clean the stables, to clean up this lifelong infection, this chronic sepsis caused by conflicts of interest whose effects were once again illustrated by fiasco of the influenza A H1N1. Make no mistake about it! What happened there is neither isolated nor unique. But the global dimension openly and media coverage have made this unhealthy situation more easily perceptible to the public.

This scandal makes everyone realize how manufacturers and their servants and political science play with our health for base economic. We should seize this as an opportunity to insist on an urgent and comprehensive reform of the system of expertise and political decision-health as a whole, preferably before public health can collapse. We must demand a radical change and not be lulled by the rocking chairs that are the speeches of mutual congratulation, as understood at the appalling meeting of the High Authority of Health dated December 10, 2009. The promising title, "Expertise and Conflicts of Interest", and timeliness of the issue did not prevent the opinion leaders present to say that everything was going well in the brave new world for conflict of interests ... (See for example the protest of the Citizen Science Foundation cons this amazing break between experts and ordinary people and the dangers it involves, on this and this, for example. The Foundation and the network which ETAL it is more proposals are well supported on these issues to the expertise, lobbying and conflicts of interest in health and in all areas).

François Autain and other senators listed below have filed January 21 a resolution "to create a commission to investigate the role of pharmaceutical companies in the management by the Government of influenza A (H1N1) v". This also means "make a transparency on the data elements issued by governments to experts, their independence and possible implications of possible conflicts of interest in the decision making of government."